Senate Bill 4160
116th Congress(2019-2020)
A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
Introduced
Introduced
Introduced in Senate on Jul 2, 2020
Overview
Text
Sponsor
Introduced
Jul 2, 2020
Latest Action
Jul 2, 2020
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4160
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
No Senate votes have been held for this bill.
Summary

This bill waives certain eligibility requirements for hospitals participating in the 340B drug discount program (i.e., a program that allows entities to receive covered outpatient drugs at reduced prices from manufacturers) during the COVID-19 (i.e., coronavirus disease 2019) public health emergency. Specifically, the bill waives the required minimum proportion of low-income patients served for hospitals that began participating in the program during or prior to the COVID-19 emergency.

Text (1)
Actions (2)
07/02/2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4225-4226)
07/02/2020
Introduced in Senate
Public Record
Created
Jul 3, 2020 4:42:10 AM
Updated
Oct 26, 2020 9:58:55 PM